Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

102.14 +1.54 (+1.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,026,303
Open 100.76
Bid (Size) 101.00 (300)
Ask (Size) 102.33 (200)
Prev. Close 100.60
Today's Range 100.58 - 102.72
52wk Range 29.91 - 112.42
Shares Outstanding 101,298,669
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Year-End Biotech Chill: Adaptive Biotechnologies Braces for J.P. Morgan Crucible Amid Market Sell-Off
As the final trading days of 2025 wind down, the biotechnology sector finds itself caught in a paradoxical "bifurcated" squeeze. While the broader indices have touched record highs this year, a sharp... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Guardant Health, Inc.
Via Business Wire

Performance

YTD
+221.5%
+221.5%
1 Month
-2.9%
-2.9%
3 Month
+63.5%
+63.5%
6 Month
+101.4%
+101.4%
1 Year
+234.4%
+234.4%

More News

Read More
News headline image
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Q3 Earnings Roundup: Cardinal Health (NYSE:CAH) And The Rest Of The Healthcare Providers & Services Segment
Via StockStory
Topics Economy
News headline image
Q3 Rundown: The Ensign Group (NASDAQ:ENSG) Vs Other Healthcare Providers & Services Stocks
Via StockStory
News headline image
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Volatile Stocks Walking a Fine Line
Via StockStory
News headline image
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium
From Guardant Health, Inc.
Via Business Wire
News headline image
Why Guardant Health (GH) Stock Is Up Today
Via StockStory
News headline image
Healthcare Providers & Services Stocks Q3 Recap: Benchmarking AMN Healthcare Services (NYSE:AMN)
Via StockStory
News headline image
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy
News headline image
Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
News headline image
Healthcare Providers & Services Stocks Q3 In Review: Pediatrix Medical Group (NYSE:MD) Vs Peers
Via StockStory
News headline image
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy
News headline image
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
Via Benzinga
News headline image
3 Mid-Cap Stocks That Concern Us
Via StockStory
News headline image
Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access
From Guardant Health, Inc.
Via Business Wire
News headline image
Healthcare Providers & Services Stocks Q3 In Review: McKesson (NYSE:MCK) Vs Peers
Via StockStory
News headline image
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in Upcoming Investor Conferences
From Guardant Health, Inc.
Via Business Wire
News headline image
1 Growth Stock with All-Star Potential and 2 That Underwhelm
Via StockStory
News headline image
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Guardant Health, Inc.
Via Business Wire
News headline image
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
From Guardant Health, Inc.
Via Business Wire

Frequently Asked Questions

Is Guardant Health, Inc. - Common Stock publicly traded?
Yes, Guardant Health, Inc. - Common Stock is publicly traded.
What exchange does Guardant Health, Inc. - Common Stock trade on?
Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Guardant Health, Inc. - Common Stock?
The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
What is the current price of Guardant Health, Inc. - Common Stock?
The current price of Guardant Health, Inc. - Common Stock is 102.14
When was Guardant Health, Inc. - Common Stock last traded?
The last trade of Guardant Health, Inc. - Common Stock was at 12/31/25 04:00 PM ET
What is the market capitalization of Guardant Health, Inc. - Common Stock?
The market capitalization of Guardant Health, Inc. - Common Stock is 10.35B
How many shares of Guardant Health, Inc. - Common Stock are outstanding?
Guardant Health, Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.